agilon health, inc. (NYSE:AGL – Free Report) – Investment analysts at Leerink Partnrs raised their Q2 2023 earnings per share estimates for shares of agilon health in a research note issued to investors on Tuesday, August 1st. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $0.01 per share for the quarter, up from their previous estimate of ($0.01). The consensus estimate for agilon health’s current full-year earnings is ($0.10) per share. Leerink Partnrs also issued estimates for agilon health’s Q3 2023 earnings at ($0.01) EPS, Q4 2023 earnings at ($0.08) EPS, FY2023 earnings at ($0.04) EPS, Q1 2024 earnings at $0.12 EPS, Q4 2024 earnings at ($0.01) EPS, FY2025 earnings at $0.55 EPS and FY2026 earnings at $0.99 EPS.
A number of other research firms have also issued reports on AGL. Truist Financial dropped their price target on agilon health from $35.00 to $27.00 in a research report on Tuesday, June 20th. Evercore ISI assumed coverage on agilon health in a research report on Tuesday, June 13th. They issued an “inline” rating and a $22.50 price target for the company. Stifel Nicolaus upped their price objective on agilon health from $29.00 to $32.00 in a report on Wednesday, May 10th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on agilon health from $28.00 to $27.00 in a report on Monday, May 15th. Seven research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $29.28.
agilon health Price Performance
agilon health (NYSE:AGL – Get Free Report) last posted its quarterly earnings data on Tuesday, May 9th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. agilon health had a negative return on equity of 7.98% and a negative net margin of 2.88%. The company had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.08 billion.
Hedge Funds Weigh In On agilon health
Several hedge funds have recently made changes to their positions in the company. Signaturefd LLC increased its position in agilon health by 58.0% in the 1st quarter. Signaturefd LLC now owns 1,144 shares of the company’s stock valued at $27,000 after acquiring an additional 420 shares during the period. First Horizon Advisors Inc. increased its position in agilon health by 41.2% in the 1st quarter. First Horizon Advisors Inc. now owns 1,553 shares of the company’s stock valued at $37,000 after acquiring an additional 453 shares during the period. Van ECK Associates Corp increased its position in agilon health by 41.5% in the 4th quarter. Van ECK Associates Corp now owns 2,738 shares of the company’s stock valued at $44,000 after acquiring an additional 803 shares during the period. US Bancorp DE increased its position in agilon health by 93.7% in the 1st quarter. US Bancorp DE now owns 2,425 shares of the company’s stock valued at $58,000 after acquiring an additional 1,173 shares during the period. Finally, Ossiam increased its position in agilon health by 43.1% in the 1st quarter. Ossiam now owns 2,831 shares of the company’s stock valued at $67,000 after acquiring an additional 853 shares during the period.
Insiders Place Their Bets
In other news, insider Benjamin Shaker sold 18,750 shares of the stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $16.97, for a total value of $318,187.50. Following the sale, the insider now directly owns 79,543 shares in the company, valued at $1,349,844.71. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, insider Veeral Desai sold 4,500 shares of the stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $26.15, for a total value of $117,675.00. Following the transaction, the insider now owns 299,585 shares of the company’s stock, valued at $7,834,147.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Benjamin Shaker sold 18,750 shares of the stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $16.97, for a total value of $318,187.50. Following the completion of the transaction, the insider now directly owns 79,543 shares in the company, valued at approximately $1,349,844.71. The disclosure for this sale can be found here. Insiders have sold 94,240,804 shares of company stock worth $1,960,196,923 over the last ninety days. Corporate insiders own 3.60% of the company’s stock.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
- Five stocks we like better than agilon health
- Transportation Stocks Investing
- 3 Best Meme ETFs to Buy Now
- How to Invest in Hotel Stocks
- XPO Keeps Reaching New Highs: Markets Love the Stock
- The How and Why of Investing in Gold Stocks
- Starbucks Market at a Turning Point: Is a Breakout Imminent?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.
